GW Pharma’s CBD Drug Profits Soar in 2nd Quarter 2019
GW Pharmaceuticals reports that sales of its CBD drug Epidiolex more than doubled in the second quarter of 2019, demonstrating that cannabinoid-based…
See our Cookie Privacy Policy Here